| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |